← back to search

Mark G. Martens

Drexel University · US
Area of research
Epidemiology · Microbiology
Research interest
Research interests include Reproductive tract infections research, Urinary Tract Infections Management, Cervical Cancer and HPV Research, and Preterm Birth and Chorioamnionitis.
h-index
34
citations
4,500
works
176
NIH funding
primary concept
Medicine
email

Recent publications

Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study
Nature Communications 2024cited by 57position: middledoi
Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathology
Science Translational Medicine 2024cited by 24position: middledoi
Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis.
2022cited by 26position: contributordoi
Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial
The Lancet Infectious Diseases 2020cited by 75position: middledoi
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study
The Lancet Infectious Diseases 2016cited by 192position: middledoi
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study
The Lancet 2014cited by 182position: middledoi
Efficacy of the HPV-16/18 AS04-Adjuvanted Vaccine Against Low-Risk HPV Types (PATRICIA Randomized Trial): An Unexpected Observation
The Journal of Infectious Diseases 2013cited by 83position: middledoi
Type-Specific Identification of Anogenital Herpes Simplex Virus Infections by Use of a Commercially Available Nucleic Acid Amplification Test
Journal of Clinical Microbiology 2012cited by 42position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Keith R. Jerome · University of Washington1 papers (2012–2012)Christine Rehm · Sanofi (France)1 papers (2020–2020)Barbara Van Der Pol · University of North Carolina at Chapel Hill1 papers (2012–2012)Josh Chen · Vertex Pharmaceuticals (United States)1 papers (2020–2020)Guy de Bruyn · Sanofi (United States)1 papers (2020–2020)Carlos Fernando de Magalhães Francesconi · Universidade Federal do Rio Grande do Sul1 papers (2020–2020)Richard Gesser · Sanofi (United States)1 papers (2020–2020)David Gordon · National Health and Medical Research Council1 papers (2020–2020)Paul Anantharajah Tambyah · National University of Singapore1 papers (2020–2020)Thelma Laot · Taguig City University1 papers (2020–2020) · 1 papers (2012–2012)Julián Torre‐Cisneros · Instituto de Salud Carlos III1 papers (2020–2020)Stephanie N. Taylor · University of Alabama at Birmingham1 papers (2012–2012)Steve Self · Precision for Medicine (United States)1 papers (2020–2020)Ehab Bassily · Sanofi (United States)1 papers (2020–2020)Edward W. Hook · University of Alabama at Birmingham1 papers (2012–2012)Robert Jeanfreau · East Jefferson General Hospital1 papers (2020–2020)Ernesto Oviedo‐Orta · Regeneron (United States)1 papers (2020–2020)Odile Launay · Assistance Publique – Hôpitaux de Paris1 papers (2020–2020) · 1 papers (2012–2012)